Imunoterapi untuk kanker paru-paru Dokter Terbaik di Israel - TOP-4 dokter

Prof. Merimsky mengepalai Unit Onkologi Jaringan Lunak dan Tulang di Sourasky Medical Center, dengan pengalaman lebih dari 40 tahun dalam penelitian dan pengobatan imunoterapi kanker paru-paru.

• Berspesialisasi dalam protokol imunoterapi untuk kasus kanker paru-paru stadium lanjut
• Anggota fakultas ESMO untuk sarkoma dan onkologi toraks
• Mantan Ketua Masyarakat Onkologi dan Radioterapi Israel
• Menulis lebih dari 50 makalah penelitian tentang imunologi tumor dan terapi target

Peneliti terkemuka dalam imunoterapi kanker paru-paru – Dr. Raphael mempelopori studi pengurutan repertoar sel-T di Sourasky Medical Center.

• Peneliti utama untuk berbagai uji klinis imunoterapi pada NSCLC
• Moderator Molecular Tumor Board untuk Perhimpunan Kanker Paru Israel
• Spesialisasi dalam profil genomik dan teknik biopsi cair
• Dianugerahi sebagai pengajar luar biasa di Universitas Tel-Aviv
• Anggota perhimpunan onkologi IASLC dan ESMO

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.